External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ELCC 2024
Roche and Genentech at

ELCC 2024

March 20 - March 23
Prague, Czech Republic
elcc.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
04:50 PM
Duration 5mins South Hall 2
Primary results from IMscin002: A study to evaluate patient- and healthcare professional-reported preferences for atezolizumab subcutaneous vs intravenous for the treatment of non-small cell lung cancer
Federico Cappuzzo, Zanete Zvirbule, Ernesto Korbenfeld, Jaroslaw Kolb-Sielecki, Dolores Isla, Amparo Yovanna Castro Sanchez, Alberto Bustillos, Lucia Xiaoyan Liu, Fiona Young, Margarita Majem
Oncology | Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:00 AM
Duration 45mins Prague, Czech Republic
ReAlec interim analysis: An observational study to evaluate the real-world clinical management and outcomes of patients with advanced ALK+ NSCLC treated with alectinib
Emilio Bria, Jair Bar, Maximilian Johannes Hochmair, Luis Mas, Miroslav Samarzija6, Julian Fecker, Joseline Ojaimi, Vlatka Smoljanović, Malinda Itchins
Oncology | Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.